Meyonex Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Palghar, Maharashtra, India, established in 2015.
2015 Palghar, Maharashtra, India Active
Last Updated:
Access Report
About Meyonex Pharmaceuticals Limited

Meyonex Pharmaceuticals Limited, a active public limited company, was established on 17 January 2015 in Palghar, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74120MH2015PLC261024. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹14.00 Cr.

Formerly known as Aveo Pharmaceuticals Limited. It upholds a compliant status. Employing 48 professional, Its leadership includes Arvind Awadhnath Sharma (Director), Vinod Kumar Sharma (Director), Shivani Sharma (Additional Director). Past directors included Bijoy Deb, Varun Sharma, Arvind Kumar Sharma. It holds ₹21.02 Cr open charges and ₹2.50 M settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No C - 13 Midc Tarapur Palghar, Palghar, Maharashtra, 401506.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74120MH2015PLC261024

  • Registration Number

    261024

  • Incorporation Date

    17 January 2015

  • Authorized Capital

    ₹20.00 Cr

  • Paid-Up Capital

    ₹14.00 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 20.00 Cr
  • Paid Up Capital ₹ 14.00 Cr
  • Company Age 11 Year, 28 Days
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 21.02 Cr
  • Satisfied Charges ₹ 2.50 M
  • Revenue Growth **** 73.16%
  • Profit Growth **** 94.54%
  • Ebitda **** 140.12%
  • Net Worth 75.14%
  • Total Assets **** 69.76%
Company report

Meyonex Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Meyonex Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Meyonex Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Arvind Awadhnath Sharma Director 17 Jan 2015 Current
Vinod Kumar Sharma Director 28 Mar 2018 Current
Shivani Sharma Additional Director 04 Oct 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 06 Oct 2025 Past
Pramod Abcsdd Director 08 Mar 2025 Past
Pramod Abcsdd Director 13 Aug 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Meyonex Pharmaceuticals.

Aveo Pharmaceuticals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 73.16% increase. The company also saw a substantial improvement in profitability, with a 94.54% increase in profit. The company's net worth Soared by an impressive increase of 75.14%.

Meyonex Pharmaceuticals revenue growth over time
Meyonex Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 73.16%
*******
*******
*******
*******
Revenue from Operations
*******
 77.04%
*******
*******
*******
*******
Total Assets
*******
 69.76%
*******
*******
*******
*******
Profit or Loss
*******
 94.54%
*******
*******
*******
*******
Net Worth
*******
 75.14%
*******
*******
*******
*******
EBITDA
*******
 140.12%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Meyonex Pharmaceuticals?

In 2024, Meyonex Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹210,150,000.00

Satisfied Charges

₹2,500,000.00

Charges Breakdown by Lending Institutions
  • Others : 21.02 Cr
Latest Charge Details
Date Lender Amount Status
28 Oct 2023 Others ₹2.41 Cr Open
26 Sep 2023 Others ₹11.00 Cr Open
26 Sep 2023 Others ₹6.11 Cr Open
08 Feb 2023 Others ₹1.50 Cr Open
20 Apr 2021 Hdfc Bank Limited ₹2.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Meyonex Pharmaceuticals?

Meyonex Pharmaceuticals has a workforce of 48 employees as of Jul 31, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Meyonex Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meyonex Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Meyonex Pharmaceuticals
Recent Activity within the Organization
  • Charges

    Progress on A charge with Others of Rs. 11.00 Cr registered on 26 Sep 2023 with Charge ID 100815040 was modified on 31 Jan 2025. was documented.

  • Director Appointment

    The activity Shivani Sharma was appointed as a Additional Director was appointed as a Additional Director on 04 Oct 2024 & has been associated with this company since 1 year 4 months . was completed.

  • Annual General Meeting

    Progress on Meyonex Pharmaceuticals Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was documented.

  • Charges

    A charge with Others of Rs. 6.11 Cr registered on 26 Sep 2023 with Charge ID 100815031 was modified on 29 May 2024. was recorded as a recent event.

  • Charges

    A charge registered on 20 Apr 2021 via Charge ID 100445895 with Hdfc Bank Limited was fully satisfied on 31 Mar 2024. was recorded as a recent event.

  • Balance Sheet

    Progress on Meyonex Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Meyonex Pharmaceuticals Limited?

The CIN of Meyonex Pharmaceuticals Limited is U74120MH2015PLC261024.

Where is Meyonex Pharmaceuticals Limited headquartered?

Meyonex Pharmaceuticals Limited is headquartered at Plot No C - 13 Midc Tarapur Palghar, Palghar, Maharashtra, 401506.

When was Meyonex Pharmaceuticals Limited incorporated?

Meyonex Pharmaceuticals Limited was incorporated on 17 January 2015.

Who are the current directors of Meyonex Pharmaceuticals Limited?

The current directors of Meyonex Pharmaceuticals Limited are

What is the primary industry of Meyonex Pharmaceuticals Limited?

The primary industry of Meyonex Pharmaceuticals Limited is Manufacturing.

Is Meyonex Pharmaceuticals Limited a listed company?

Meyonex Pharmaceuticals Limited is unlisted.

What is the capital structure of Meyonex Pharmaceuticals Limited?

The authorized capital of Meyonex Pharmaceuticals Limited is ₹20.00 Cr, and the paid-up capital is ₹14.00 Cr.

What is the compliance status of Meyonex Pharmaceuticals Limited?

The compliance status of Meyonex Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available